Tardive Dyskinesia and Tardive Dystonia with Second-Generation Antipsychotics in Bipolar Disorder Patients Unexposed to First-Generation Antipsychotics |
Lee, Ahram
(Department of Psychiatry, Sungkyunkwan University School of Medicine, Samsung Medical Center)
Kim, Joo Hyun (Department of Psychiatry, Sungkyunkwan University School of Medicine, Samsung Medical Center) Baek, Ji Hyun (Department of Psychiatry, Sungkyunkwan University School of Medicine, Samsung Medical Center) Kim, Ji Sun (Department of Neuropsychiatry, Seoul National University Bundang Hospital, Seoul National University College of Medicine) Choi, Mi Ji (Center for Clinical Research, Samsung Biomedical Research Institute) Yoon, Se Chang (Department of Psychiatry, Sungkyunkwan University School of Medicine, Samsung Medical Center) Ha, Kyooseob (Department of Neuropsychiatry, Seoul National University Bundang Hospital, Seoul National University College of Medicine) Hong, Kyung Sue (Department of Psychiatry, Sungkyunkwan University School of Medicine, Samsung Medical Center) |
1 | Sachs GS, Grossman F, Ghaemi SN, Okamoto A, Bowden CL. Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety. Am J Psychiatry 2002;159:1146-1154. DOI |
2 | Kane JM. Tardive dyskinesia rates with atypical antipsychotics in adults: prevalence and incidence. J Clin Psychiatry 2004;65 Suppl 9:16-20. |
3 | Jeste DV. Tardive dyskinesia rates with atypical antipsychotics in older adults. J Clin Psychiatry 2004;65 Suppl 9:21-24. |
4 | Casey DE. Implications of the CATIE trial on treatment: extrapyramidal symptoms. CNS Spectr 2006;11(7 Suppl 7):25-31. DOI |
5 | Meyer JM. Antipsychotic safety and efficacy concerns. J Clin Psychiatry 2007;68 Suppl 14:20-26. DOI |
6 | Sachdev PS. Neuroleptic-induced movement disorders: an overview. Psychiatr Clin North Am 2005;28:255-274. DOI |
7 | Dinan TG, Kohen D. Tardive dyskinesia in bipolar affective disorder: relationship to lithium therapy. Br J Psychiatry 1989;155:55-57. DOI |
8 | Waddington JL, Youssef HA. Tardive dyskinesia in bipolar affective disorder: aging, cognitive dysfunction, course of illness, and exposure to neuroleptics and lithium. Am J Psychiatry 1988;145:613-616. DOI |
9 | Eberhard J, Lindstrom E, Levander S. Tardive dyskinesia and antipsychotics: a 5-year longitudinal study of frequency, correlates and course. Int Clin Psychopharmacol 2006;21:35-42. DOI |
10 | Ghaemi SN, Hsu DJ, Rosenquist KJ, Pardo TB, Goodwin FK. Extrapyramidal side effects with atypical neuroleptics in bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry 2006;30:209-213. DOI |
11 | Coplan J, Gugger JJ, Tasleem H. Tardive dyskinesia from atypical antipsychotic agents in patients with mood disorders in a clinical setting. J Affect Disord 2013;150:868-871. DOI |
12 | Woods SW, Morgenstern H, Saksa JR, Walsh BC, Sullivan MC, Money R, et al. Incidence of tardive dyskinesia with atypical versus conventional antipsychotic medications: a prospective cohort study. J Clin Psychiatry 2010;71:463-474. DOI |
13 | van Harten PN, Kahn RS. Tardive dystonia. Schizophr Bull 1999;25:741-748. DOI |
14 | Bassitt DP, de Souza Lobo Garcia L. Risperidone-induced tardive dyskinesia. Pharmacopsychiatry 2000;33:155-156. DOI |
15 | Papapetropoulos S, Wheeler S, Singer C. Tardive dystonia associated with ziprasidone. Am J Psychiatry 2005;162:2191. DOI |
16 | Sevincok L, Balci V, Akyildiz U. Tardive dystonia associated with low-dose of amisulpride: a case report. J Clin Psychopharmacol 2008;28:573-574. DOI |
17 | Burke RE, Fahn S, Jankovic J, Marsden CD, Lang AE, Gollomp S, et al. Tardive dystonia: late-onset and persistent dystonia caused by antipsychotic drugs. Neurology 1982;32:1335-1346. DOI |
18 | Gimenez-Roldan S, Mateo D, Bartolome P. Tardive dystonia and severe tardive dyskinesia. A comparison of risk factors and prognosis. Acta Psychiatr Scand 1985;71:488-494. DOI |
19 | Kane JM. Tardive dyskinesia: epidemiological and clinical presentation. In: Bloom FE, Kupfer DJ, editors. Psychopharmacology: The Fourth Generation of Progress. New York: Raven Press;1995. p.1485-1495. |
20 | Sachdev P. Tardive blepharospasm. Mov Disord 1998;13:947-951. DOI |
21 | Chouinard G, Ross-Chouinard A, Annable L, Jones B. The extrapyramidal symptom rating scale. Can J Neurol Sci 1980;7:233. |
22 | van Harten PN, Hoek HW, Matroos GE, Koeter M, Kahn RS. The inter-relationships of tardive dyskinesia, parkinsonism, akathisia and tardive dystonia: the Curaçao Extrapyramidal Syndromes Study II. Schizophr Res 1997;26:235-242. DOI |
23 | Crane GE. Persistent dyskinesia. Br J Psychiatry 1973;122:395-405. DOI |
24 | Guy W. Abnormal Involuntary Movement Scale, in ECDEU: Assessment Manual for Psychopharmacology. Washington, DC: US Department of Health, Education and Welfare;1976. |
25 | Schooler NR, Kane JM. Research diagnoses for tardive dyskinesia. Arch Gen Psychiatry 1982;39:486-487. |
26 | American Psychiatric Association. Diagnostic And Statistical Manual of Mental Disorders: DSM-4. 4th ed. Washington, DC: Americal Psychiatric Association;2000. |
27 | Ryu S, Yoo JH, Kim JH, Choi JS, Baek JH, Ha K, et al. Tardive dyskinesia and tardive dystonia with second-generation antipsychotics in non-elderly schizophrenic patients unexposed to first-generation antipsychotics: a cross-sectional and retrospective study. J Clin Psychopharmacol 2015;35:13-21. DOI |
28 | Sachdev P. Risk factors for tardive dystonia: a case-control comparison with tardive dyskinesia. Acta Psychiatr Scand 1993;88:98-103. DOI |
29 | Nasrallah HA, Churchill CM, Hamdan-Allan GA. Higher frequency of neuroleptic-induced dystonia in mania than in schizophrenia. Am J Psychiatry 1988;145:1455-1456. DOI |
30 | Smulevich AB, Khanna S, Eerdekens M, Karcher K, Kramer M, Grossman F. Acute and continuation risperidone monotherapy in bipolar mania: a 3-week placebo-controlled trial followed by a 9-week double-blind trial of risperidone and haloperidol. Eur Neuropsychopharmacol 2005;15:75-84. DOI |
31 | Tohen M, Goldberg JF, Gonzalez-Pinto Arrillaga AM, Azorin JM, Vieta E, Hardy-Bayle MC, et al. A 12-week, double-blind comparison of olanzapine vs haloperidol in the treatment of acute mania. Arch Gen Psychiatry 2003;60:1218-1226. DOI |
32 | Tohen M, Baker RW, Altshuler LL, Zarate CA, Suppes T, Ketter TA, et al. Olanzapine versus divalproex in the treatment of acute mania. Am J Psychiatry 2002;159:1011-1017. DOI |
33 | Nasrallah HA, Brecher M, Paulsson B. Placebo-level incidence of extrapyramidal symptoms (EPS) with quetiapine in controlled studies of patients with bipolar mania. Bipolar Disord 2006;8(5 Pt 1):467-474. DOI |
34 | Keck PE Jr, Versiani M, Potkin S, West SA, Giller E, Ice K. Ziprasidone in the treatment of acute bipolar mania: a three-week, placebocontrolled, double-blind, randomized trial. Am J Psychiatry 2003;160:741-748. DOI |
35 | Keck PE Jr, Calabrese JR, McQuade RD, Carson WH, Carlson BX, Rollin LM, et al. A randomized, double-blind, placebo-controlled 26-week trial of aripiprazole in recently manic patients with bipolar I disorder. J Clin Psychiatry 2006;67:626-637. DOI |
36 | Waddington JL, Brown K, O'Neill J, McKeon P, Kinsella A. Cognitive impairment, clinical course and treatment history in out-patients with bipolar affective disorder: relationship to tardive dyskinesia. Psychol Med 1989;19:897-902. DOI |
37 | Kane JM. Tardive dyskinesia in affective disorders. J Clin Psychiatry 1999;60 Suppl 5:43-47. |
38 | Tarsy D, Simon DK. Dystonia. N Engl J Med 2006;355:818-829. DOI |
39 | Mukherjee S, Rosen AM, Caracci G, Shukla S. Persistent tardive dyskinesia in bipolar patients. Arch Gen Psychiatry 1986;43:342-346. DOI |